UY30707A1 - Pirazoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion - Google Patents

Pirazoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion

Info

Publication number
UY30707A1
UY30707A1 UY30707A UY30707A UY30707A1 UY 30707 A1 UY30707 A1 UY 30707A1 UY 30707 A UY30707 A UY 30707A UY 30707 A UY30707 A UY 30707A UY 30707 A1 UY30707 A1 UY 30707A1
Authority
UY
Uruguay
Prior art keywords
compositions
pirazols
replaced
contain
manufacturing
Prior art date
Application number
UY30707A
Other languages
English (en)
Inventor
Tabart Michel
Mauger Jacques
Nair Anil
Bjergarde Kirsten
Patek Marcel
Dodson Mark
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of UY30707A1 publication Critical patent/UY30707A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C273/00—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C273/18—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups of substituted ureas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Lqa presente invencion se refiere principalmente aw compuestos químicos nuevos, particularmente a pirazoles sustituidos, a las composiciones que los contienen, y a su utilizacion como medicamentos.
UY30707A 2006-11-10 2007-11-09 Pirazoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion UY30707A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0609812A FR2908409B1 (fr) 2006-11-10 2006-11-10 Pyrazoles substituees,compositions les contenant,procede de fabrication et utilisation

Publications (1)

Publication Number Publication Date
UY30707A1 true UY30707A1 (es) 2008-07-03

Family

ID=38169388

Family Applications (1)

Application Number Title Priority Date Filing Date
UY30707A UY30707A1 (es) 2006-11-10 2007-11-09 Pirazoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion

Country Status (40)

Country Link
US (3) US7989439B2 (es)
EP (1) EP2091920B1 (es)
JP (1) JP5538893B2 (es)
KR (1) KR20090083456A (es)
CN (1) CN101553473B (es)
AR (1) AR063638A1 (es)
AU (1) AU2007327423B2 (es)
BR (1) BRPI0718999A2 (es)
CA (1) CA2667846A1 (es)
CL (1) CL2007003251A1 (es)
CO (1) CO6190516A2 (es)
CR (1) CR10749A (es)
CY (1) CY1116000T1 (es)
DK (1) DK2091920T3 (es)
DO (1) DOP2009000088A (es)
EA (1) EA019454B1 (es)
EC (1) ECSP099312A (es)
ES (1) ES2528385T3 (es)
FR (1) FR2908409B1 (es)
HK (1) HK1137988A1 (es)
HN (1) HN2009000856A (es)
HR (1) HRP20150070T1 (es)
IL (1) IL198328A0 (es)
MA (1) MA30972B1 (es)
MX (1) MX2009004983A (es)
MY (1) MY147502A (es)
NI (1) NI200900078A (es)
NO (1) NO20091990L (es)
NZ (1) NZ576709A (es)
PE (2) PE20121152A1 (es)
PL (1) PL2091920T3 (es)
PT (1) PT2091920E (es)
SI (1) SI2091920T1 (es)
SV (1) SV2009003253A (es)
TN (1) TN2009000155A1 (es)
TW (1) TW200829556A (es)
UA (1) UA97965C2 (es)
UY (1) UY30707A1 (es)
WO (1) WO2008065282A2 (es)
ZA (1) ZA200903560B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7858323B2 (en) * 2004-06-09 2010-12-28 The Regents Of The University Of Michigan Phage microarray profiling of the humoral response to disease
FR2947546B1 (fr) * 2009-07-03 2011-07-01 Sanofi Aventis Derives de pyrazoles, leur preparation et leur application en therapeutique
UY33200A (es) * 2010-01-26 2011-08-31 Sanofi Aventis Derivados de ácido 3-heteroaroilamino-propiónico sustituidos con oxígeno y su uso como productos farmacéuticos
TWI523844B (zh) 2011-01-26 2016-03-01 賽諾菲公司 經胺基取代之３－雜芳醯基胺基－丙酸衍生物及其作為藥物之用途
CN102432639B (zh) * 2011-09-30 2013-11-06 山东大学 1-(2-羟基-3-(苯氨基)丙基)-3-二茂铁基-1h-吡唑-5-甲酸乙酯化合物及其应用
AP2015008381A0 (en) 2012-11-02 2015-04-30 Pfizer Bruton's tyrosine kinase inhibitors
MX2017012295A (es) 2015-03-25 2018-01-09 Novartis Ag Derivados formilados n-heterociclicos como inhibidores de fgfr4.
CN107619388A (zh) * 2016-07-13 2018-01-23 南京天印健华医药科技有限公司 作为fgfr抑制剂的杂环化合物
CN107840842A (zh) 2016-09-19 2018-03-27 北京天诚医药科技有限公司 炔代杂环化合物、其制备方法及其在医药学上的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6878714B2 (en) * 2001-01-12 2005-04-12 Amgen Inc. Substituted alkylamine derivatives and methods of use
EP1461334A2 (en) * 2001-04-27 2004-09-29 Vertex Pharmaceuticals Incorporated Pyrazole derived kinase inhibitors
CA2522079A1 (en) * 2003-04-16 2004-11-04 Astrazeneca Ab Quinazoline derivatives for treatment of cancer
US20040220186A1 (en) * 2003-04-30 2004-11-04 Pfizer Inc. PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, and cardiovascular disease
KR101204247B1 (ko) * 2003-07-22 2012-11-22 아스텍스 테라퓨틱스 리미티드 3,4-이치환된 1ｈ-피라졸 화합물 및 그의 시클린 의존성키나제 (ｃｄｋ) 및 글리코겐 합성효소 키나제-3(ｇｓｋ-3) 조정제로서 용도
JP2008505167A (ja) * 2004-07-05 2008-02-21 アステックス、セラピューティックス、リミテッド 医薬組成物
JP2008509982A (ja) * 2004-08-16 2008-04-03 プロシディオン・リミテッド アリール尿素誘導体
JP2008526723A (ja) * 2004-12-30 2008-07-24 アステックス、セラピューティックス、リミテッド Ｃｄｋ、ｇｓｋ及びオーロラキナーゼの活性を調節するピラゾール誘導体
AR053662A1 (es) * 2005-01-21 2007-05-16 Astex Therapeutics Ltd Compuestos de pirazol inhibidores de la actividad quinasa cdk y gsk
JP2008528469A (ja) * 2005-01-21 2008-07-31 アステックス・セラピューティクス・リミテッド ピラゾールキナーゼ阻害剤およびさらなる抗癌剤の組合せ剤
EP1683796A1 (en) * 2005-01-24 2006-07-26 Schering Aktiengesellschaft Pyrazolopyridines, their preparation and their medical use
FR2947546B1 (fr) * 2009-07-03 2011-07-01 Sanofi Aventis Derives de pyrazoles, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
FR2908409A1 (fr) 2008-05-16
CN101553473A (zh) 2009-10-07
EA200970472A1 (ru) 2009-10-30
NI200900078A (es) 2010-01-27
WO2008065282A2 (fr) 2008-06-05
ECSP099312A (es) 2009-06-30
US7989439B2 (en) 2011-08-02
CL2007003251A1 (es) 2009-08-07
DK2091920T3 (en) 2015-01-26
MX2009004983A (es) 2009-05-22
HN2009000856A (es) 2011-10-19
PL2091920T3 (pl) 2015-04-30
US20090291984A1 (en) 2009-11-26
AU2007327423A1 (en) 2008-06-05
PT2091920E (pt) 2015-02-05
US20110237801A1 (en) 2011-09-29
HK1137988A1 (en) 2010-08-13
DOP2009000088A (es) 2013-06-15
SV2009003253A (es) 2009-10-27
PE20081162A1 (es) 2008-10-02
WO2008065282A3 (fr) 2008-07-31
HRP20150070T1 (hr) 2015-02-27
PE20121152A1 (es) 2012-09-07
NO20091990L (no) 2009-06-02
US8420824B2 (en) 2013-04-16
FR2908409B1 (fr) 2009-01-09
KR20090083456A (ko) 2009-08-03
JP5538893B2 (ja) 2014-07-02
ES2528385T3 (es) 2015-02-09
UA97965C2 (ru) 2012-04-10
US20110237641A1 (en) 2011-09-29
MY147502A (en) 2012-12-14
NZ576709A (en) 2011-08-26
MA30972B1 (fr) 2009-12-01
CR10749A (es) 2009-07-23
CO6190516A2 (es) 2010-08-19
JP2010509297A (ja) 2010-03-25
TN2009000155A1 (fr) 2010-10-18
IL198328A0 (en) 2010-02-17
AR063638A1 (es) 2009-02-04
BRPI0718999A2 (pt) 2014-02-25
EP2091920B1 (fr) 2014-10-22
EA019454B1 (ru) 2014-03-31
US8410286B2 (en) 2013-04-02
AU2007327423B2 (en) 2012-09-06
EP2091920A2 (fr) 2009-08-26
SI2091920T1 (sl) 2015-02-27
CN101553473B (zh) 2013-06-05
ZA200903560B (en) 2010-08-25
TW200829556A (en) 2008-07-16
CA2667846A1 (fr) 2008-06-05
CY1116000T1 (el) 2017-01-25

Similar Documents

Publication Publication Date Title
UY30707A1 (es) Pirazoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion
HN2008000188A (es) 7- aza- indazoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y su utilizacion
HN2006018410A (es) Nuevos derivados del fluoreno, composiciones que los contienen y utilizacion
PA8660301A1 (es) Pirazolo piridinas sustituidas, composiciones que las contienen, procedimiento de fabricacion y utilizacion
HN2003000094A (es) Indazoles subtituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion.
CR9463A (es) Pirrolinas sustituidas, composiciones que las contienen, proceso de fabricacion y utilizacion
UY31260A1 (es) Compuestos de pirazol, composiciones conteniendolos y aplicaciones.
SV2011003855A (es) Heteroarilos sustituidos
UY30470A1 (es) Compuestos heteroarilos de cinco heteroatomos sustituidos con fenilo conteniendo nitrogeno, composiciones farmacéuticas y aplicaciones.
HN2008000088A (es) Heterociclicos de 1,4-dihidropiridina- fusionada, procesos para preparar los mismos, su uso y las composiciones que los contienen.
PA8654701A1 (es) Indoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion
CR20110381A (es) Antagonistas de 4-azetidinil-1-heteroaril-ciclohexanol de ccr2
UY28350A1 (es) Productos aril-heteroaromaticos, composiciones que los contienen y su utilización
TW200738627A (en) Trialkylsilyl-indoles
CR10548A (es) 18-metil-19nor-androst-4-en-17, 17-espiroeteres (18-metil-19-nor-20-espirox-4-en-3-onas) asi como preparaciones farmaceuticas que los contienen
HN2010001537A (es) Nuevos derivados dihidroindolonas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
SV2006002384A (es) Pirazolo piridinas sustituidas, composiciones que las contienen, procedimiento de fabricacion y utilizacion
CR11392A (es) Derivados de pirazol como inhibidores de 5-lo
CR9231A (es) Pirroles sustituidos, composiciones que los contienen, procesos de fabricacion y utilizacion
UY32101A (es) Compuestos de triazol, su uso, así como productos que los contienen
UY33092A (es) Compuestos de triazol, su uso y agentes que los contienen
UY32103A (es) Compuestos de triazol, su uso, así como productos que los contienen
UY32102A (es) Compuestos de triazol, su uso, así como productos que los contienen
UY29390A1 (es) Derivados nuevos de 3-aril-1,2-bencisoxazol, composiciones que los contienen y su utilización.
NI201000139A (es) ASOCIACION DE UN INHIBIDOR DE CORRIENTE SINUSAL If Y DE UN BETA-BLOQUEANTE

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20170904